Digital medical devices: What guarantees?
Digital tools are revolutionizing many sectors, including the medical field. Digital medical devices are tools that use digital technologies to help patients monitor their health status or to facilitate medical care. They are becoming increasingly popular and are considered valuable tools for improving the quality of healthcare.
However, with the growing use of these digital devices, guarantees regarding their effectiveness and safety have become a major concern. Manufacturers of these devices must ensure that their products comply with current safety standards and regulations to avoid potential health risks for patients.
The role of manufacturers
Digital medical devices are subject to strict quality standards, regulated in France by the ANSM (National Agency for the Safety of Medicines and Health Products) and in the United States by the FDA (Food and Drug Administration). These agencies review digital medical devices to ensure they are safe, effective, and high-quality.
Manufacturers of these devices must also ensure that their products comply with regulations regarding patient privacy protection. The data collected by these medical devices must be securely stored and in accordance with the GDPR.
Thus, it is important for manufacturers of these digital medical devices to work closely with regulatory authorities and healthcare professionals to ensure the effectiveness and safety of their products.
Since 2021, European Regulation 2017/745 has definitively replaced Directives 93/42/EEC and 90/385/EEC. It defines a medical device as “any instrument, apparatus, equipment, software, implant, reagent, material or other article, intended by the manufacturer to be used, alone or in combination, for one or more of the following specific medical purposes:
- diagnosis, prevention, monitoring, prediction, prognosis, treatment or alleviation of a disease
- diagnosis, monitoring, treatment, alleviation of an injury or disability or compensation for them
- investigation, replacement or modification of an anatomical structure or of a physiological or pathological process or state
- communication of information by means of in vitro examination of samples derived from the human body, including organ, blood, and tissue donations
- and whose principal intended action in or on the human body is not achieved by pharmacological or immunological means or by metabolism, but whose function may be assisted by such means.”
These requirements depend on different criteria, including the intended purpose of the medical device and its risk class. There are four classes for medical devices, in order of criticality: I, IIa, IIb, and III. This criticality depends on the risk to the patient, healthcare personnel, or any other person involved during the use of the device.
A notified body (NB), chosen by the medical device manufacturer, performs the conformity assessment (except for certain class I medical devices, where this responsibility is placed on the manufacturer).
In January 2022, the European Parliament and the Council adopted a staggered extension of its transition period, ranging from May 26, 2025, for high-risk in vitro diagnostics to May 26, 2027, for low-risk in vitro diagnostics, and May 26, 2028, for certain provisions concerning devices manufactured and used in healthcare facilities.
Informing patients
Patients must also be informed of the potential risks associated with the use of these digital medical devices, as well as the measures they can take to minimize these risks. Patients must also be aware of the warranties associated with these devices, particularly in terms of efficacy and safety, and be encouraged to communicate with their healthcare professionals to discuss the use of these digital medical devices.
Patients must also be informed of the potential risks associated with the use of these digital medical devices, as well as the measures they can take to minimize these risks. Patients must also be aware of the warranties associated with these devices, particularly in terms of efficacy and safety, and be encouraged to communicate with their healthcare professionals to discuss the use of these digital medical devices.
In conclusion, digital medical devices offer significant benefits for both patients and healthcare professionals. However, to ensure their efficacy and safety, it is important that manufacturers work in close collaboration with regulatory authorities and healthcare professionals, and that patients are informed of potential risks and the measures they can take to minimize these risks. With these guarantees in place, digital medical devices can continue to play an important role in improving healthcare.